Gufic Biosciences Limited (BOM:509079)
India · Delayed Price · Currency is INR 314.00
0.00 (0.00%)
At close: Feb 12, 2026
Gufic Biosciences Market Cap
Gufic Biosciences has a market cap or net worth of 31.49 billion as of February 12, 2026. Its market cap has decreased by -26.30% in one year.
Market Cap
31.49B
Enterprise Value
34.30B
Revenue
8.74B
Ranking
n/a
PE Ratio
55.33
Stock Price
314.00
Market Cap Chart
Since March 5, 2001, Gufic Biosciences's market cap has increased from 357.14M to 31.49B, an increase of 8,717.01%. That is a compound annual growth rate of 19.66%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 12, 2026 | 31.49B | -6.76% |
| Dec 31, 2025 | 33.77B | -26.14% |
| Dec 31, 2024 | 45.72B | 44.52% |
| Dec 29, 2023 | 31.64B | 43.80% |
| Dec 30, 2022 | 22.00B | -4.54% |
| Dec 31, 2021 | 23.05B | 153.22% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| FDC Limited | 63.50B |
| Unichem Laboratories | 27.24B |
| Hikal | 23.58B |
| Bliss GVS Pharma | 22.67B |
| Morepen Laboratories | 21.73B |
| Novartis India | 20.50B |
| Shukra Pharmaceuticals | 19.47B |
| Amrutanjan Health Care | 18.66B |